Substituted pyrazolo-pyrazines and their use as GluN2B receptor modulators | Patent Number 11993587

US 11993587 B2
Application Number17618068
Publication NumberUS 20220315590 A1
Pendency3 years, 11 months, 21 days
Filled DateJun 12, 2020
Priority DateJun 14, 2019
Publication DateOct 6, 2022
Expiration DateJun 13, 2039
Inventor/ApplicantsHeather Coate
Heather COATE
Curt DVORAK
Curt Dvorak
Examines-
Art Unit0
Technology Center0
Assignments
Janssen Pharmaceuticals Johnson & Johnson
Current
Janssen Pharmaceuticals Johnson & JohnsonJohnson & Johnson
Original
Law Firm
You must be logged in to view
Login
Attorneys
Subscription-Only
View Concierge Program
Patent Prosecution report image

Empower your practice with Patexia Publication Prosecution IP Module.

Get access to our exclusive rankings and unlock powerful data.
Check our Latest ReportPurchase IP Module

Looking for a Publication Attorney?

Get in touch with our team or create your account to start exploring a network of over 120K attorneys.